EndoFLIP assessment of pyloric sphincter in children: a single-center experience

Mara Popescu1, Emily White2, Mohamed Mutalib1,2

  • 1Faculty of Life Sciences and Medicine, Kings College London, London, UK.

Insights

Children with neurodisabilities and foregut symptoms often have poor pyloric distensibility. Intrapyloric Botulinum Toxin improved symptoms and pyloric measurements in this study.

Area of Science:

  • Pediatric Gastroenterology
  • Neurodisability Research
  • Medical Device Technology

Background:

  • Gastrointestinal issues like vomiting and poor feeding are prevalent in children with neurodisabilities.
  • The Endolumenal functional lumen imaging probe (EndoFLIP) assesses pyloric compliance and distensibility, predicting treatment response in adults with gastroparesis.
  • This study focuses on pyloric measurements using EndoFLIP in pediatric patients with neuromuscular disabilities and foregut symptoms.

Purpose of the Study:

  • To review pyloric muscle measurements obtained via EndoFLIP in children with neuromuscular disabilities.
  • To evaluate the clinical effectiveness of intrapyloric Botulinum Toxin in this patient group.
  • To correlate EndoFLIP measurements with clinical outcomes.

Main Methods:

  • A retrospective review of clinical notes from March 2019 to January 2022 at Evelina London Children's Hospital.
  • EndoFLIP catheter insertion via an existing gastrostomy tract during endoscopy.
  • Pyloric measurements (diameter, compliance, distensibility) were taken pre- and post-Botulinum Toxin injection at various balloon volumes.

Main Results:

  • 335 measurements from 12 children (mean age 10.7 years) were analyzed.
  • Significant improvements in diameter, compliance, and distensibility were observed post-Botulinum Toxin injection.
  • Eleven out of twelve children reported clinical symptom improvement.

Conclusions:

  • Children with neurodisabilities and foregut symptoms exhibit reduced pyloric distensibility and compliance.
  • EndoFLIP assessment via a gastrostomy tract is a feasible and rapid procedure.
  • Intrapyloric Botulinum Toxin demonstrated safety and efficacy, improving both clinical symptoms and objective measurements in this pediatric cohort.
Abstract

Related Concept Videos

Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
117
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
164
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
185
Endoscopic Procedures I: Esophagogastroduodenoscopy01:29

Endoscopic Procedures I: Esophagogastroduodenoscopy

An Esophagogastroduodenoscopy (EGD) is a diagnostic procedure in which an endoscopist uses a flexible, lighted endoscope to visualize the upper gastrointestinal (GI) tract. The procedure includes visualizing the oropharynx, esophagus, stomach, and the first part of the small intestine, the duodenum.
During an EGD, the endoscope can be used to:
249
Endoscopic Procedures V: ERCP01:26

Endoscopic Procedures V: ERCP

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
494
Gastric Emptying01:16

Gastric Emptying

Gastric emptying occurs when the stomach gradually releases chyme into the duodenum. When the stomach is distended, it triggers the release of gastrin, a hormone that promotes gastric acid secretion to aid in digestion. Additionally, stomach distension contributes to peristaltic waves that propel gastric contents toward the pyloric region. The gastroenteric reflex, on the other hand, primarily stimulates peristalsis in the intestines, facilitating the movement of contents further along the...
1.0K